Analysis of therapeutic effect of ilex hainanensis Merr. extract on nonalcoholic fatty liver disease through urine metabolite profiling by ultraperformance liquid chromatography/quadrupole time of flight mass spectrometry

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Li, Jing Jing ^a   Yang, Jie ^a   Cui, Wei Xi ^a   Chen, Xiao Qing ^b   Chen, Gang Ling ^a   Wen, Xiao Dong ^a   Wang, Qiang ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ILEX HAINANENSIS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIPID DIET; MALE; METABOLISM; METABOLITE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; RAT; SCREENING; THERAPY EFFECT; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINE;

EID: 84884242377     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/451975     Document Type: Article

References (31)

1. de Wit N. J., Afman L. A., Mensink M., Phenotyping the effect of diet on non-alcoholic fatty liver disease. Journal of Hepatology 2012 57 6 1370 1373
2. Li H., Wang L., Yan X., Liu Q., Yu C., Wei H., Li Y., Zhang X., He F., Jiang Y., A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease. Journal of Proteome Research 2011 10 6 2797 2806 2-s2.0-79958186715 10.1021/pr200047c
3. Barr J., Vázquez-Chantada M., Alonso C., Pérez-Cormenzana M., Mayo R., Galán A., Caballería J., Martín-Duce A., Tran A., Wagner C., Luka Z., Lu S. C., Castro A., Le Marchand-Brustel Y., Martínez-Chantar M. L., Veyrie N., Clément K., Tordjman J., Gual P., Mato J. M., Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. Journal of Proteome Research 2010 9 9 4501 4512 2-s2.0-77956326416 10.1021/pr1002593
4. Salt W. B. II, Nonalcoholic fatty liver disease (NAFLD): a comprehensive review. Journal of Insurance Medicine 2004 36 1 27 41 2-s2.0-2942738940
5. Gao Y., Song L.-X., Jiang M.-N., Ge G.-Y., Jia Y.-J., Effects of traditional Chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. Inflammation 2008 31 2 121 132 2-s2.0-45449103635 10.1007/s10753-008-9057-3
6. Zhao W. X., Liu X. Y., Duan R. Z., Effect of Xiaozhihugan capsule on pathologic changes and CYP2E1 gene expression of rats with non-alcoholic fatty liver. China Journal of Traditional Chinese Medicine and Pharmacy 2007 22 6 363 366
7. Department of Health of Guangxi Zhuang Minority Autonomous Region, Chinese Medicinal Materials Standard of Guangxi 1990 Nanning, China Guangxi Science and Technology Press
8. Hang C. L., Cao Q. R., Tea-based Traditional Chinese medicine resource-Shanlvcha. Journal of Chinese Medicinal Materials 1984 3 18 36
9. Wei X. L., Chen X. Q., Fang R. T., Preventive effects of flavonoid extracts from Ilex hainanensis Merr. on rats with hepatic steatosis induced by a high-fat diet. Drug Development Research 2012 73 8 308 316
10. Chen X.-Q., Zan K., Liu H., Yang J., Lai M.-X., Wang Q., Triterpenes and flavonoids from Ilex hainanensis Merr. (Aquifoliaceae). Biochemical Systematics and Ecology 2009 37 5 678 682 2-s2.0-72549104258 10.1016/j.bse.2009.08.006
11. Zhou S.-X., Yang J.-S., Liu F.-C., Tu P.-F., Triterpenoids from the leaves of Ilex hainanensis. Helvetica Chimica Acta 2007 90 1 121 127 2-s2.0-33846637401 10.1002/hlca.200790005
12. Nicholson J. K., Lindon J. C., Holmes E., "Metabonomics": understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999 29 11 1181 1189 2-s2.0-0032694577
13. Nicholson J. K., Connelly J., Lindon J. C., Holmes E., Metabonomics: a platform for studying drug toxicity and gene function. Nature Reviews Drug Discovery 2002 1 2 153 161 2-s2.0-0036463681 10.1038/nrd728
14. Gowda G. A. N., Zhang S., Gu H., Asiago V., Shanaiah N., Raftery D., Metabolomics-based methods for early disease diagnostics. Expert Review of Molecular Diagnostics 2008 8 5 617 633 2-s2.0-52049108458 10.1586/14737159.8.5. 617
15. Kaddurah-Daouk R., Kristal B. S., Weinshilboum R. M., Metabolomics: a global biochemical approach to drug response and disease. Annual Review of Pharmacology and Toxicology 2008 48 653 683 2-s2.0-41149162296 10.1146/annurev.pharmtox.48.113006.094715
16. Jiang P., Dai W., Yan S., Chen Z., Xu R., Ding J., Xiang L., Wang S., Liu R., Zhang W., Biomarkers in the early period of acute myocardial infarction in rat serum and protective effects of Shexiang Baoxin Pill using a metabolomic method. Journal of Ethnopharmacology 2011 138 2 530 536 2-s2.0-81255127401 10.1016/j.jep.2011.09.049
17. Yang B., Zhang A., Sun H., Dong W., Yan G., Li T., Wang X., Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2012 58 1 113 124 2-s2.0-80255129393 10.1016/j.jpba.2011.09.033
18. Tan G. G., Liao W. T., Dong X., Yang G., Zhu Z., Li W., Chai Y., Lou Z., Metabonomic profiles delineate the effect of traditional Chinese medicine Sini decoction on myocardial infarction in rats. PLoS ONE 2012 7 4 2-s2.0-84859510098 10.1371/journal.pone.0034157 e34157
19. Zhang A. H., Sun H., Wu X. H., Urine metabolomics. Clinica Chimica Acta 2012 414 24 65 69
20. Hong X. Z., Li L. D., Wu L. M., Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease. Clinical and Experimental Pharmacology and Physiology 2007 34 1-2 27 35 2-s2.0-33846113313 10.1111/j.1440-1681.2007.04547.x
21. Li P., Robertson T. A., Thorling C. A., Zhang Q., Fletcher L. M., Crawford D. H. G., Roberts M. S., Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Drug Metabolism and Disposition 2011 39 4 571 579 2-s2.0-79952851326 10.1124/dmd.110.036806
22. Lv Y., Liu X., Yan S., Liang X., Yang Y., Dai W., Zhang W., Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2010 52 1 129 135 2-s2.0-74249085418 10.1016/j.jpba.2009.12.016
23. 1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet. Analytical and Bioanalytical Chemistry 2009 395 4 1117 1124 2-s2.0-70349759319 10.1007/s00216-009-3054-8
24. Bringolf M., Zaragoza N., Rivier D., Felber J. P., Studies on the metabolic effects induced in the rat by a high-fat diet. Inhibition of pyruvate metabolism in diaphragm in vitro and its relation to the oxidation of fatty acids. European Journal of Biochemistry 1972 26 3 360 367 2-s2.0-0015502665
25. Daugherity E. K., Balmus G., Al Saei A., The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease. Cell Cycle 2012 11 10 1918 1928
26. Walker J. B., Metabolic control of creatine biosynthesis-II. Restoration of transamidinase activity following creatine repression. The Journal of Biological Chemistry 1961 236 493 498 2-s2.0-78651134314
27. Xie B. G., Waters M. J., Schirra H. J., Investigating potential mechanisms of obesity by metabolomics. Journal of Biomedicine and Biotechnology 2012 2012 10 805683 10.1155/2012/805683
28. Konishi F., The relationship of urinary 17-hydroxycorticosteroids to creatinine in obesity. Metabolism 1964 13 9 847 851 2-s2.0-50549194501
29. Schirra H. J., Anderson C. G., Wilson W. J., Kerr L., Craik D. J., Waters M. J., Lichanska A. M., Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabonomics and microarray study. PLoS ONE 2008 3 7 2-s2.0-50649120799 10.1371/journal.pone.0002764 e2764
30. Satoh H., Cardioprotective actions of taurine against intracellular and extracellular calcium-induced effects. Advances in Experimental Medicine and Biology 1994 359 181 196 2-s2.0-0028062027
31. Klein M. S., Dorn C., Saugspier M., Hellerbrand C., Oefner P. J., Gronwald W., Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy. Metabolomics 2011 7 2 237 246 2-s2.0-79957516472 10.1007/s11306-010-0243-6